166 related articles for article (PubMed ID: 11329015)
1. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors.
Hüser A; Rudolph M; Hofmann C
Nat Biotechnol; 2001 May; 19(5):451-5. PubMed ID: 11329015
[TBL] [Abstract][Full Text] [Related]
2. Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein.
Guibinga GH; Friedmann T
Mol Ther; 2005 Apr; 11(4):645-51. PubMed ID: 15771967
[TBL] [Abstract][Full Text] [Related]
3. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system.
Hofmann C; Strauss M
Gene Ther; 1998 Apr; 5(4):531-6. PubMed ID: 9614578
[TBL] [Abstract][Full Text] [Related]
4. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
5. Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1.
Hofmann C; Hüser A; Lehnert W; Strauss M
Biol Chem; 1999 Mar; 380(3):393-5. PubMed ID: 10223343
[TBL] [Abstract][Full Text] [Related]
6. Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice.
Hoare J; Waddington S; Thomas HC; Coutelle C; McGarvey MJ
J Gene Med; 2005 Mar; 7(3):325-33. PubMed ID: 15521052
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.
Kaname Y; Tani H; Kataoka C; Shiokawa M; Taguwa S; Abe T; Moriishi K; Kinoshita T; Matsuura Y
J Virol; 2010 Apr; 84(7):3210-9. PubMed ID: 20071581
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of double-expression retroviral vector using complement regulatory factor gene.
Hayashi S; Emi N; Okada H; Yokoyama I; Takagi H
J Surg Res; 1998 Jul; 78(1):64-7. PubMed ID: 9733620
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
Xu L; Shao H; Wu W; Cao Z; Zhao Z; Liu H; Jiang D; Mao X; Li W
Int J Mol Med; 2005 Sep; 16(3):409-14. PubMed ID: 16077947
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
12. How to avoid complement attack in baculovirus-mediated gene delivery.
Kaikkonen MU; Ylä-Herttuala S; Airenne KJ
J Invertebr Pathol; 2011 Jul; 107 Suppl():S71-9. PubMed ID: 21784233
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
[TBL] [Abstract][Full Text] [Related]
14. Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement.
Guibinga GH; Friedmann T
Cold Spring Harb Protoc; 2010 Jul; 2010(7):pdb.prot5420. PubMed ID: 20647353
[TBL] [Abstract][Full Text] [Related]
15. Neuronal gene transfer by baculovirus-derived vectors accommodating a neurone-specific promoter.
Li Y; Yang Y; Wang S
Exp Physiol; 2005 Jan; 90(1):39-44. PubMed ID: 15542616
[TBL] [Abstract][Full Text] [Related]
16. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
17. Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery.
Kaikkonen MU; Maatta AI; Ylä-Herttuala S; Airenne KJ
Mol Ther; 2010 May; 18(5):987-92. PubMed ID: 20179675
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.
Hüser A; Hofmann C
Am J Pharmacogenomics; 2003; 3(1):53-63. PubMed ID: 12562216
[TBL] [Abstract][Full Text] [Related]
19. Establishment of complement-resistant retroviral vector by homologous restriction factor 20 gene.
Hayashi S; Emi N; Okada H; Nagasaka T; Yokoyama I; Takagi H
Gene Ther; 1998 Feb; 5(2):282-5. PubMed ID: 9578850
[TBL] [Abstract][Full Text] [Related]
20. Efficient and stable gene expression in rabbit intervertebral disc cells transduced with a recombinant baculovirus vector.
Liu X; Li K; Song J; Liang C; Wang X; Chen X
Spine (Phila Pa 1976); 2006 Apr; 31(7):732-5. PubMed ID: 16582845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
